CALDAN THERAPEUTICS LIMITED

Company number SC515558

Date	Type	Description	View / Download
16 Dec 2020	CH01	Director's details changed for Dr Mark Anthony Payton on 16 December 2020	(2 pages)
11 Dec 2020	AA	Accounts for a small company made up to 30 September 2020	(31 pages)
16 Jun 2020	CS01	Confirmation statement made on 12 June 2020 with updates	(8 pages)
16 Jun 2020	PSC05	Change of details for Epidarex Capital Ii Lp as a person with significant control on 12 June 2020	(2 pages)
16 Jun 2020	CH01	Director's details changed for Dr Elizabeth Ann Roper on 12 June 2020	(2 pages)
11 Dec 2019	AA	Accounts for a small company made up to 30 September 2019	(28 pages)
17 Oct 2019	SH01	Statement of capital following an allotment of shares on 7 October 2019 GBP 7,857.650	(9 pages)
16 Oct 2019	RESOLUTIONS	Resolutions RES10 ‐ Resolution of allotment of securities	(1 page)
01 Oct 2019	SH01	Statement of capital following an allotment of shares on 18 September 2019 GBP 7,763.932	(9 pages)
06 Aug 2019	AP01	Appointment of Dr Mark Anthony Payton as a director on 31 July 2019	(2 pages)
06 Aug 2019	AP01	Appointment of Dr Henning Klaus-Willi Christian Steinhagen as a director on 31 July 2019	(2 pages)
06 Aug 2019	TM01	Termination of appointment of Peter Michael Finan as a director on 31 July 2019	(1 page)
05 Jul 2019	SH01	Statement of capital following an allotment of shares on 19 June 2019 GBP 7,447.155	(9 pages)
27 Jun 2019	AP01	Appointment of Dr Michael Alexander Dalrymple as a director on 19 June 2019	(2 pages)
27 Jun 2019	RESOLUTIONS	Resolutions RES10 ‐ Resolution of allotment of securities RES01 ‐ Resolution of adoption of Articles of Association	(92 pages)
13 Jun 2019	CS01	Confirmation statement made on 12 June 2019 with updates	(5 pages)
09 Apr 2019	AA	Accounts for a small company made up to 30 September 2018	(17 pages)
06 Dec 2018	PSC07	Cessation of Scottish Enterprise as a person with significant control on 6 April 2016	(1 page)
06 Dec 2018	PSC07	Cessation of Epidarex Capital Partners Limited as a person with significant control on 6 April 2016	(1 page)
23 Aug 2018	SH01	Statement of capital following an allotment of shares on 26 July 2018 GBP 5,229.719	(9 pages)
23 Aug 2018	RESOLUTIONS	Resolutions RES10 ‐ Resolution of allotment of securities	(1 page)
15 Jun 2018	CS01	Confirmation statement made on 12 June 2018 with updates	(5 pages)
03 Jan 2018	AA	Full accounts made up to 30 September 2017	(24 pages)
15 Dec 2017	CH01	Director's details changed for Mr Frank Murdoch Armstrong on 14 December 2017	(2 pages)
01 Nov 2017	SH01	Statement of capital following an allotment of shares on 5 October 2017 GBP 5,217.397	(5 pages)